Current Challenges in Cell and Gene Therapy
Regulatory
This live webinar shed light on the various aspects of Cell and Gene Therapy. Three industry experts shared their experience and knowledge on the regulatory, manufacturing and logistical challenges within the cell and gene therapy (CGT) space.
Presentations:
- Updates on CGT Regulations in Australia by Dr George Vuckovic
- Manufacturing and Regulatory Challenges in Allogenic Cell Therapies by Harsha Gupta
- Logistical Challenges in CGT Clinical Trials by Manfred Seow
Key topics:
- CGT regulatory pathways in Australia
- Autologous, allogenic and gene cell therapies
- Manufacturing challenges
- CGT logistics
Speakers:
- Dr George Vuckovic (Therapeutic Goods Administration, Australia)
- Harsha Gupta (Cynata, Australia)
- Manfred Seow (IQVIA, Singapore)
The presentation and recording from the webinar are available here:
Click here for more information about our Asia-Pac events.
Related Education Resources.
All ResourcesEMA Guidance on Trial Mgmt during COVID-19
Topics: Health Care, Pharma Industry, Strategic Planning
Guidance Document
Free
Countdown to Brexit: Can your clinical supply chain pass the Brexit pressure test
Topics: Pharma Industry, Politics
White Paper
Members
The Exponential Growth of Decentralized Trials, Direct-to-Patient and the Future of the Clinical Trials Landscape in Europe
Topics: Conference, Regulatory
Executive Summary
Members
